Price T Rowe Associates Inc. MD Has $201.71 Million Position in Perrigo Company plc (NYSE:PRGO)

Price T Rowe Associates Inc. MD increased its holdings in Perrigo Company plc (NYSE:PRGO - Free Report) by 6,828.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,845,539 shares of the company's stock after purchasing an additional 7,732,309 shares during the quarter. Price T Rowe Associates Inc. MD owned approximately 5.75% of Perrigo worth $201,710,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also bought and sold shares of the company. Headlands Technologies LLC raised its stake in Perrigo by 1,942.0% during the 4th quarter. Headlands Technologies LLC now owns 1,409 shares of the company's stock valued at $36,000 after purchasing an additional 1,340 shares during the period. Versant Capital Management Inc purchased a new position in shares of Perrigo in the 4th quarter worth approximately $45,000. GAMMA Investing LLC boosted its holdings in shares of Perrigo by 93.7% in the 4th quarter. GAMMA Investing LLC now owns 1,920 shares of the company's stock worth $49,000 after purchasing an additional 929 shares during the period. Central Pacific Bank Trust Division boosted its holdings in Perrigo by 33.3% during the 4th quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company's stock valued at $51,000 after acquiring an additional 500 shares during the period. Finally, Venturi Wealth Management LLC boosted its holdings in Perrigo by 97.8% during the 4th quarter. Venturi Wealth Management LLC now owns 4,215 shares of the company's stock valued at $108,000 after acquiring an additional 2,084 shares during the period. 95.91% of the stock is owned by institutional investors.

Perrigo Trading Down 1.7 %

Perrigo stock traded down $0.44 during trading on Thursday, hitting $25.29. The company had a trading volume of 828,468 shares, compared to its average volume of 1,524,449. The company's 50 day simple moving average is $26.55 and its 200-day simple moving average is $26.07. The stock has a market cap of $3.45 billion, a price-to-earnings ratio of -21.61 and a beta of 0.49. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94. Perrigo Company plc has a 1-year low of $23.14 and a 1-year high of $33.46.

Perrigo (NYSE:PRGO - Get Free Report) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.93 earnings per share for the quarter, beating analysts' consensus estimates of $0.92 by $0.01. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The firm had revenue of $1.14 billion during the quarter, compared to analysts' expectations of $1.20 billion. As a group, analysts expect that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Perrigo Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 17th. Stockholders of record on Friday, May 30th will be issued a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a dividend yield of 4.59%. Perrigo's dividend payout ratio (DPR) is -92.80%.

Insider Activity at Perrigo

In other Perrigo news, EVP Ronald Craig Janish sold 7,800 shares of Perrigo stock in a transaction on Monday, March 10th. The shares were sold at an average price of $27.44, for a total value of $214,032.00. Following the completion of the transaction, the executive vice president now owns 33,666 shares of the company's stock, valued at $923,795.04. The trade was a 18.81 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Insiders own 0.70% of the company's stock.

Analysts Set New Price Targets

PRGO has been the subject of several research reports. Piper Sandler cut Perrigo from an "overweight" rating to a "neutral" rating and lowered their target price for the stock from $34.00 to $27.00 in a report on Monday, January 6th. StockNews.com cut shares of Perrigo from a "buy" rating to a "hold" rating in a research note on Wednesday, February 19th. Finally, Argus cut shares of Perrigo from a "buy" rating to a "hold" rating in a research note on Tuesday, January 14th. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $33.00.

Perrigo Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.